CuraYou's ProWave Deep Healing Pad™ delivers red and infrared light therapy for wound healing in a form patients can use at home, translating clinical research built with professional-grade lasers into a wearable device that works between medical appointments and alongside standard wound care. The research behind photobiomodulation for wound healing is substantial: a 2024 meta-analysis of 18 randomized controlled trials found that treated wounds healed significantly faster and more completely than untreated controls, and three independent meta-analyses have confirmed significant benefit for diabetic foot ulcers specifically. But clinical evidence does not help a patient sitting at home with a slow-healing wound unless it translates into a device they can use. The specifics matter: which wavelengths, why LEDs rather than lasers, what treatment protocols CuraYou recommends, and the duration and frequency parameters that connect the device's engineering to the clinical research. The full science lives in our complete guide to red light therapy for wound healing; this article is about how one device implements it.
This article is part of our complete guide to Red Light Therapy for Wound Healing.
Key Takeaways
- Device specifications matched to the research: The Cura ProWave Deep Healing Pad™ delivers 850nm near-infrared light from 240 light chips and 660nm red light from 120 light chips (360 total), both wavelengths falling within the therapeutic ranges studied in the wound healing clinical literature: 630–670nm for the mitochondrial energy response in superficial tissue and 808–860nm for deeper tissue penetration, inflammation modulation, and immune cell reprogramming.
- LED mechanisms are supported by direct clinical evidence: The biological pathways of photobiomodulation are wavelength-dependent, not device-dependent. A 2026 systematic review comparing LED and laser effects on cutaneous wound healing (Miranda et al.) confirmed that both light sources are effective, with outcomes varying by parameters rather than by device type.
- Protocol aligned with clinical trial parameters: CuraYou recommends daily 20-minute sessions placed directly over or adjacent to the wound site, consistent with the treatment frequencies and durations that produced the strongest results in the clinical trials. The pre-set wound healing mode eliminates the need to configure settings manually, and the three treatment modes (red only, infrared only, combined) allow targeted application based on wound type and depth.
- Timeline of results: Clinical trials report measurable improvements in wound size within two to four weeks of consistent treatment, with treatment courses typically running two to twelve weeks depending on wound type and severity. CuraYou's 60-day risk-free return policy covers this clinical window, so users can evaluate whether the therapy is producing visible results before committing.
What the Research Requires
How Red and Infrared Light Therapy Address Wound Healing
Red and near-infrared light therapy (photobiomodulation) accelerates wound healing through eight distinct biological mechanisms that operate across every phase of repair. The therapy restores cellular energy production in tissue where mitochondrial function is impaired, reduces the chronic inflammation that keeps wounds stuck in the inflammatory phase, reprograms immune cells from tissue destruction to tissue repair, stimulates the proliferation and migration of fibroblasts and keratinocytes, promotes new blood vessel formation and improves microcirculation, enhances collagen synthesis while reducing the matrix-degrading enzymes that destroy it, manages the oxidative stress that damages cells at the wound site, and reduces wound pain (Taha et al., 2024); (Da Rocha et al., 2024). Together, these mechanisms address wound healing at the cellular level, the level where chronic wounds and slow-healing surgical wounds actually fail. The clinical evidence behind these mechanisms now includes a meta-analysis of 18 randomized controlled trials showing significantly greater wound size reduction and complete healing rates, three independent meta-analyses in diabetic foot ulcers (Huang et al., 2021); (Chen et al., 2025); (Miranda et al., 2025), and a network meta-analysis ranking photobiomodulation highest among 12 interventions for diabetic foot ulcer wound area reduction. The complete science behind each mechanism is detailed in our guide to red light therapy for wound healing.
Wavelength, Dosimetry, and Protocol Parameters
For any device to deliver these benefits, the research defines specific requirements. Red light wavelengths in the 630–670nm range target cytochrome c oxidase, the mitochondrial enzyme that drives the cellular energy response, and are most effective for superficial tissue repair, collagen stimulation, and keratinocyte migration (Dompe et al., 2020); (Mathioudaki et al., 2023). Near-infrared wavelengths in the 808–860nm range penetrate deeper into tissue, reaching the vasculature, deeper wound beds, and immune cells to drive angiogenesis, macrophage polarization from M1 to M2, and inflammation resolution (Shi et al., 2026); (Ferreira et al., 2025). The combination of both wavelength ranges addresses wounds at multiple tissue depths simultaneously.
Energy densities across the clinical wound healing trials ranged from 1.5 to 10 J/cm² at the treatment area, with most effective protocols clustering between 2 and 6 J/cm² (Taha et al., 2024). The strongest clinical results came from protocols using daily or near-daily sessions, continued for two to twelve weeks depending on wound severity. A 2024 systematic review confirmed that LED-based photobiomodulation stimulates cell proliferation, migration, angiogenesis, collagen deposition, and inflammatory modulation across all phases of healing, with red wavelengths especially effective for cell migration and proliferation.
The therapy has shown no serious adverse events across the published clinical trials. The Taha et al. and Huang et al. meta-analyses both reported no significant adverse events in the treatment groups. But effectiveness depends on delivering the right wavelengths at sufficient irradiance for an adequate duration, at consistent power output, and with appropriate treatment frequency. Underpowered protocols, inconsistent power delivery, or insufficient treatment duration reduce or eliminate the therapeutic benefit. The research is clear that photobiomodulation follows a biphasic dose response: both too little and too much energy reduce effectiveness (Hamblin, 2017).
Regarding timeline: expect measurable wound size improvements within two to four weeks of consistent daily use. In the Wadee et al. head-to-head trial comparing photobiomodulation to hyperbaric oxygen therapy for diabetic foot ulcers, the light therapy group showed favorable wound volume reduction in the first four weeks. Full treatment courses in the clinical trials typically ran two to twelve weeks, depending on wound type and severity. Chronic wounds with significant underlying comorbidities (diabetes, vascular disease) generally require longer treatment courses. This is an adjunctive therapy that builds results cumulatively through consistent application.
Most of the chronic wounds I see aren't failing because the patient is doing something wrong. They're failing because the cells at the wound site don't have what they need to do their job. The blood supply is poor, the inflammation won't settle, the fibroblasts are sluggish. We manage the wound as well as we can from the outside, with dressings and debridement, but you can't make tired cells work harder with a bandage. What draws me to the photobiomodulation data is that it targets that exact level. For diabetic foot ulcers especially, where the meta-analysis evidence has gotten strong, it gives us something that works on the biology standard wound care just can't reach.— Dr. William Carter, MD
Why the Cura ProWave Deep Healing Pad™ Uses LEDs Instead of Lasers
Most of the clinical evidence for photobiomodulation in wound healing comes from professional-grade laser devices used in clinical settings. If the strongest evidence base uses lasers, why does the Cura ProWave Deep Healing Pad™ use LEDs?
The Biology Does Not Require a Laser
The cellular mechanisms of photobiomodulation are wavelength-dependent, not device-dependent. A photon at 660nm triggers the same mitochondrial response regardless of whether it originates from a laser or an LED. Hamblin (2017), in a widely cited review in AIMS Biophysics, stated that all studies comparing lasers to equivalent LED sources at similar wavelength and power density have found essentially no difference between them, and that LEDs work equally well as lasers for photobiomodulation. A 2026 systematic review by Miranda et al., which directly compared LED and laser effects on cutaneous wound healing across experimental studies, confirmed that both light sources are effective, with outcomes varying by treatment parameters rather than by device type. That equivalence is established in controlled comparisons where wavelength and energy density are precisely matched; translating it from lab conditions to a consumer device introduces variables (tissue contact angle, distance from wound surface, session-to-session positioning) that comparison studies do not fully isolate, which is why device engineering and protocol design matter as much as the photon source.
Lasers Carry Safety Risks Unsuitable for Home Use
Clinical lasers used in the wound healing trials are Class 3B or Class 4 medical devices that can cause eye damage upon direct or reflected exposure and require trained operators, controlled environments, and protective eyewear. For a patient managing a wound at home, these requirements make clinical lasers impractical. LED devices at the irradiance levels used in consumer photobiomodulation devices operate well within safe limits for unsupervised home use, with no risk of eye injury from the device itself at normal operating distances and no risk of thermal tissue damage at therapeutic parameters.
Larger Treatment Area Is an Advantage for Wound Healing
Lasers focus energy on a small spot, typically requiring point-by-point application across the wound surface and surrounding tissue. For wound healing, where the treatment area includes the wound bed, wound margins, and surrounding tissue that supplies the healing response, broad-area coverage is the better match. A systematic review by Cronshaw, Parker & Grootveld (2020) found that larger optical spot sizes were associated with better clinical outcomes for both superficial and deeper targets, while multiple small-diameter probe applications produced inconsistent results. The Cura ProWave Deep Healing Pad™'s 18-by-8-inch treatment surface covers the wound and surrounding tissue in a single application, eliminating the coverage gaps and inconsistency inherent in point-by-point approaches.
LED Enables Daily Home Use During Wound Treatment
The clinical trials that produced the strongest wound healing outcomes used daily or near-daily treatment frequencies continued over weeks. Clinical laser protocols require a patient to visit a clinic or hospital for each session. For a patient already managing wound care appointments, daily clinic visits solely for light therapy are impractical. An LED pad device enables the same daily frequency the clinical evidence shows is critical, delivered at home without requiring specialized training or clinical supervision, and can be applied while sitting or resting.
How the CuraYou ProWave Deep Healing Pad™ Delivers Photobiomodulation for Wound Healing
Wavelengths
The Cura ProWave Deep Healing Pad™ is built around 120 medical-grade triple-chip LEDs: 240 near-infrared light chips at 850nm and 120 red light chips at 660nm. Both wavelengths sit within the therapeutic ranges documented in the wound healing research.
The 660nm red light falls within the cytochrome c oxidase absorption band (630–670nm) where photobiomodulation triggers the mitochondrial energy response that damaged tissue cells need for repair. This is the same wavelength range used in the majority of wound healing clinical trials, and it matches the parameters that produced significant results in the Taha et al. meta-analysis. Red light at this wavelength has been shown to stimulate fibroblast proliferation and activity (Cavalcanti et al., 2024), accelerate keratinocyte migration across wound models (Mathioudaki et al., 2023), and modulate the inflammatory response in stressed tissue cells (Lim et al., 2013).
The 850nm near-infrared light penetrates deeper into tissue than red light, reaching the vasculature, deeper wound beds, and immune cells that red light alone does not adequately access. At 850nm, the light drives macrophage polarization from the tissue-destroying M1 state to the tissue-repairing M2 state (Shi et al., 2026); (Ferreira et al., 2025), promotes angiogenesis in ischemic tissue (Huang et al., 2021), and reduces the oxidative stress that damages cells at the wound site (Dos Santos et al., 2017). Having both wavelengths in a single device allows simultaneous treatment of superficial and deeper wound biology, an advantage over devices that deliver only one wavelength range.
Irradiance and Why It Matters for Wound Healing
The Cura ProWave Deep Healing Pad™ delivers 200 mW/cm², the highest irradiance on the consumer market. This specification has a direct consequence for wound treatment.
Photobiomodulation follows a biphasic dose response: both too little and too much energy reduce effectiveness (Hamblin, 2017). The energy dose delivered to tissue is a function of irradiance multiplied by time. Higher irradiance means the device can deliver a therapeutic dose in a practical session length, a consideration that matters for patient adherence. But irradiance at the device surface is not the same as energy at the target cells. Light scatters, reflects, and is absorbed as it passes through tissue, so the energy reaching cells at depth is always less than the energy at the surface. This is true for every photobiomodulation device, whether laser or LED.
The clinical wound healing trials used energy densities of 1.5 to 10 J/cm² at the treatment site. At 200 mW/cm², the Cura ProWave Deep Healing Pad™ delivers surface energy sufficient to achieve therapeutic tissue-level doses within these ranges during the recommended 20-minute sessions, after accounting for the energy lost to tissue attenuation. For deeper wound beds, where 850nm near-infrared light must penetrate through skin and subcutaneous tissue, having the highest available surface irradiance provides the best chance of delivering an adequate dose at depth.
Many consumer devices operate at significantly lower irradiance levels, which either fail to deliver a therapeutic dose or require impractically long session times. The difference between a device that delivers sufficient energy in 20 minutes and one that requires 60 or more minutes for the same tissue-level dose is the difference between a protocol patients will follow and one they will not.
Treatment Area Coverage
The Cura ProWave Deep Healing Pad™ measures 18 inches by 8 inches, providing one of the largest treatment areas available in a wearable consumer device. For wound healing, this matters for two reasons.
First, effective wound treatment requires irradiating not just the wound bed itself but the surrounding tissue that supplies the blood vessels, immune cells, fibroblasts, and keratinocytes that drive repair. A device that covers only the wound without reaching the tissue margin misses the cells that need to migrate into the wound.
Second, the flexible neoprene design allows the pad to wrap around curved body surfaces, including legs, feet, arms, and torso, conforming to the area around the wound so that light reaches the tissue at angles that maximize energy transfer. For diabetic foot ulcers, venous leg ulcers, and surgical wounds on the extremities, this conformability ensures contact across the treatment area rather than leaving gaps where a rigid device cannot maintain tissue proximity.
Three Separate Treatment Modes
The device offers three operating modes: red light only (660nm), infrared light only (850nm), and combined red and infrared. This matters for wound treatment because different wound types and healing phases benefit from different wavelength emphasis.
For superficial wounds where the primary goal is keratinocyte migration and surface tissue repair, red light mode (660nm) delivers the wavelength range most strongly associated with cell proliferation and migration in the wound healing research. For deeper wounds where inflammation resolution, macrophage reprogramming, angiogenesis, and deeper tissue repair are the priority, infrared mode (850nm) delivers the wavelength that penetrates to those targets. For most wound healing applications, combined mode delivers both wavelength ranges simultaneously, addressing superficial and deep wound biology in a single session.
Pre-Set Modes and Ease of Use
The Cura ProWave Deep Healing Pad™ includes pre-set treatment modes with optimal parameters for wound healing, eliminating the need for users to calculate dosimetry or configure settings manually. The large remote with big, readable buttons is designed for older adults, who represent the population most likely to be managing chronic wounds, particularly diabetic foot ulcers, venous leg ulcers, and pressure injuries. The convenient strap system secures the device in place during treatment, freeing the user's hands and allowing treatment during rest, reading, or other seated activities.
Power Delivery and Consistency
Consistent power delivery throughout each session matters because photobiomodulation's biphasic dose response means that inconsistent power output produces inconsistent energy delivery, which produces unpredictable biological response (Hamblin, 2017). The Cura ProWave Deep Healing Pad™ maintains consistent irradiance throughout each session. LED lifetime is rated at 50,000 hours, ensuring consistent output across the full useful life of the device without the power degradation that occurs in lower-quality LED products over time.
The device is a FDA Class 2 Medical Device and ISO Certified, constructed from medical-grade LEDs and neoprene, and produces 0 V/m EMF. There is no risk of burns at the operating parameters. It can be purchased with an HSA or FSA card and comes with up to 3 years of product warranty.
CuraYou's Recommended Protocol for Wound Healing
Based on the clinical research parameters and the physics of LED tissue delivery, CuraYou recommends daily 20-minute sessions with the device placed directly over or adjacent to the wound area. Combined red and infrared mode addresses both superficial tissue repair and deeper wound biology within a single session. For wounds on the extremities, wrap the pad around the affected area using the strap system to ensure full coverage of the wound and surrounding tissue.
Consistency is among the most important factors in photobiomodulation outcomes. The clinical trials that produced the strongest results used daily treatment frequencies continued over weeks. CuraYou includes a cellular restoration protocol and progress-tracking tools designed to help users build and maintain a daily treatment habit, because a device that sits in a drawer does not deliver photons to tissue.
Treatment should continue daily throughout the healing period. For acute surgical wounds or burns, two to four weeks of daily use is a reasonable starting point. For chronic wounds such as diabetic foot ulcers or venous leg ulcers, expect to use the device daily for four to twelve weeks, consistent with the treatment durations in the clinical trials. If you are not seeing measurable improvement after four weeks of consistent daily use, CuraYou's human support team can help evaluate whether adjustments to placement, session length, or treatment frequency may improve results. We are not a brand hiding behind chatbots; we work directly with customers to optimize outcomes.
Wound healing with photobiomodulation is cumulative. Each session stimulates cellular energy production, inflammation resolution, collagen synthesis, and blood vessel formation. The benefits build over a consistent treatment course, not from a single session.
Conclusion
The CuraYou ProWave Deep Healing Pad™ translates the clinical research behind red and infrared light therapy for wound healing into a device built for at-home use. The 660nm red and 850nm near-infrared LEDs deliver wavelengths within the therapeutic ranges studied across the wound healing clinical literature, including the first meta-analysis of photobiomodulation in human skin wounds. Its 200 mW/cm² irradiance, the highest on the consumer market, ensures that therapeutic energy reaches the wound and surrounding tissue within a practical 20-minute daily session. The 18-by-8-inch flexible pad covers the wound, wound margins, and surrounding tissue that supplies the healing response. Three treatment modes allow targeted application based on wound type and depth. Pre-set modes eliminate the need for manual dosimetry calculation, and the large-button remote is designed for the older adults who are most likely to need wound healing support.
Clinical trials report measurable wound size improvements within two to four weeks of consistent daily treatment, with full treatment courses running two to twelve weeks depending on wound type and severity. CuraYou's 60-day risk-free return policy covers this entire clinical window. If you are using the device consistently and not seeing the results the research supports, you get a full refund. That policy exists because the evidence supports the therapy, and we are willing to let the results speak for themselves.
The device is FDA Registered and ISO Certified, produces 0 V/m EMF, and can be purchased with an HSA or FSA card. Hundreds of verified customer reviews describe the benefits they have received from this device. CuraYou's human support team is available to help optimize therapy if needed.
Red light therapy is an adjunctive treatment. It works alongside standard wound care, not as a replacement. For wounds driven by underlying conditions such as diabetes, vascular disease, or immunosuppression, those conditions must be addressed in parallel. Patients should discuss any new wound care intervention with their healthcare provider.
